News
Icon Plc and Medpace are both CROs, but Icon focuses on large pharma with an aggressive M&A strategy, unlike Medpace's small biotech focus. Initially impressed by Icon's financials, we purchased ...
ICON plc, No. 25-cv-01807 ("PFRSD"). PFRSD is related to the class action an investor previously filed against ICON: Shing v. ICON plc, No. 25-cv-00763 (E.D.N.Y.) ("Shing"), which is the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback